Stay updated on MEDI4736 in Myelodysplastic Syndrome Clinical Trial
Sign up to get notified when there's something new on the MEDI4736 in Myelodysplastic Syndrome Clinical Trial page.

Latest updates to the MEDI4736 in Myelodysplastic Syndrome Clinical Trial page
- Check4 days agoChange Detected- Updated core content: Revision updated from v3.0.1 to v3.0.2. - Minor UI change: 'Back to Top' removed.SummaryDifference0.3%
- Check11 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. Additionally, a 'Back to Top' feature has been added for improved navigation.SummaryDifference0.3%
- Check18 days agoChange DetectedThe page has undergone significant updates, including the addition of a facility name and location in Paris, France, as well as the introduction of new medical terms related to myelodysplastic syndrome and various compounds. Notably, azacitidine and durvalumab have been removed from the page.SummaryDifference5%
- Check26 days agoNo Change Detected
- Check33 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.1%
- Check40 days agoChange DetectedThe web page has been updated from version 2.16.10 to version 2.16.11.SummaryDifference0.1%
- Check47 days agoChange DetectedThe web page has been updated to version 2.16.10, and a previous service alert regarding planned maintenance has been removed.SummaryDifference1%
Stay in the know with updates to MEDI4736 in Myelodysplastic Syndrome Clinical Trial
Enter your email address, and we'll notify you when there's something new on the MEDI4736 in Myelodysplastic Syndrome Clinical Trial page.